Welcome to our dedicated page for Innovex International SEC filings (Ticker: INVX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Innovex International, Inc. (NYSE: INVX), a Houston-based energy industrial platform operating in the Oil & Gas Equipment & Services industry. Innovex files annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K, along with any other required disclosures.
Recent Form 8-K filings referenced by the company include reports of quarterly financial results and other material events. For example, Innovex has filed 8-Ks to furnish earnings press releases for quarters ended March 31, June 30, and September 30, 2025, and to report matters such as the planned sale and subsequent closing of a legacy facility and board-related changes. These filings often incorporate press releases that discuss revenue, net income, cash flow, Adjusted EBITDA, Free Cash Flow, and Return on Capital Employed, along with reconciliations of non-GAAP measures to GAAP metrics.
Through this SEC filings page, users can review Innovex’s 10-K and 10-Q reports for detailed information on its well-centric product portfolio, risk factors, segment performance, and capital allocation approach, as described by the company. Form 4 and other ownership filings, when available, can be used to monitor transactions by directors, officers, and significant shareholders.
Stock Titan enhances these filings with AI-powered summaries that explain the key points of lengthy documents, highlight notable changes from prior periods, and clarify technical language. Real-time updates from the SEC’s EDGAR system ensure that new Innovex filings, including earnings-related 8-Ks and other material disclosures, are added promptly so investors can quickly see how the company’s regulatory reporting aligns with its public commentary on strategy, M&A, and financial performance.
Innovex International, Inc. is asking stockholders to vote at its May 7, 2026 annual meeting on three items: electing three Class II directors, ratifying PwC as auditor, and approving an advisory say‑on‑pay resolution.
The record date is March 13, 2026, when 68,563,690 common shares were outstanding, each with one vote. Amberjack Capital–affiliated funds are the largest holder with 22,757,322 shares, or 33.2%, and retain board nomination and registration rights under existing agreements. Other significant holders include Brandes Investment Partners, BlackRock and Vanguard.
The Board is majority independent, with separate Chair and CEO roles and fully independent audit, compensation, and nominating committees. Directors use a majority-voting standard in uncontested elections, and all non‑employee directors receive cash retainers plus equity awards, with stock ownership guidelines set at five times the annual cash retainer.
The proxy details 2025 executive pay for CEO Adam Anderson, CFO Kendal Reed and North America President Mark Reddout. Base salaries were $550,000 for the CEO and $375,000 for each other named executive. Annual bonuses were tied to Adjusted EBITDA, with a $195 million target and $156 million threshold. Based on 2025 Adjusted EBITDA of $188 million, executives earned 90% of target bonuses.
Long‑term incentives granted in 2025 include time‑based RSUs and performance units tied to relative total shareholder return and return on capital employed over a 2025–2027 performance period, with payouts ranging from 0% to 200% of target. The filing also describes Amberjack’s registration rights and stockholders’ agreement, including board designee rights and standstill provisions, and confirms that all Section 16(a) ownership reports were timely for 2025 except for one late Form 4 for three executives, later corrected.
Innovex International Inc: Amendment No. 3 to a Schedule 13G/A filed by The Vanguard Group reports zero shares beneficially owned of Innovex common stock. The filing explains an internal realignment on January 12, 2026 that disaggregated subsidiaries and business divisions under SEC Release No. 34-39538, resulting in separate reporting of beneficial ownership. The filing states Vanguard no longer has beneficial ownership over securities held by those subsidiaries. The form is signed by Ashley Grim on 03/27/2026.
Innovex International, Inc. disclosed that a jury in the U.S. District Court for the Southern District of Texas returned a verdict against its wholly owned subsidiary, Downhole Well Solutions, LLC, in a patent infringement case brought by Impulse Downhole Solutions entities. The jury found the remaining asserted patent claims valid, determined that DWS infringed them and characterized the infringement as willful, awarding Impulse approximately $47.6 million in damages. The damages amount may increase or decrease after further proceedings, and no judgment has been entered yet. Innovex strongly disagrees with the verdict, plans to pursue post-trial motions, and expects to appeal any judgment to the U.S. Court of Appeals for the Federal Circuit.
Innovex International, Inc. director Benjamin Matthew Fink reported an equity award of common stock. He acquired 5,465 shares of common stock on a grant/award basis at a stated price of $0.00 per share. Following this award, his directly held common stock position increased to 21,376 shares.
Anderson Adam reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that Chief Executive Officer Adam Anderson received a grant of 47,438 shares of common stock on February 27, 2026 at a stated price of $0.00 per share. Following this award, he directly owns 514,182 common shares.
Innovex International, Inc. director Jupp Terence Bartlett reported an award of 5,465 shares of common stock on February 27, 2026. The shares were acquired as a grant at a stated price of $0.00 per share, bringing his directly held stake to 89,832 common shares.
Innovex International director Sedita Angie reported a stock grant. On this Form 4, Sedita received 5,465 shares of Innovex International, Inc. common stock as a grant or award at no cost. After this acquisition, Sedita directly holds a total of 29,881 common shares.
Innovex International, Inc. director John Lovoi received a stock award of 5,465 shares of common stock on February 27, 2026, recorded as a grant or other acquisition at a stated price of $0.00 per share. After this award, his directly held common stock ownership increased to 101,427 shares.
Reddout Mark reported acquisition or exercise transactions in this Form 4 filing.
Innovex International, Inc. reported that President of North America Mark Reddout received a grant of 18,975 shares of common stock on February 27, 2026. The award was recorded at a price of $0.00 per share, bringing his directly held common stock to 148,411 shares after the transaction.